1. Home
  2. NEO vs FPF Comparison

NEO vs FPF Comparison

Compare NEO & FPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • FPF
  • Stock Information
  • Founded
  • NEO 2001
  • FPF 2013
  • Country
  • NEO United States
  • FPF United States
  • Employees
  • NEO N/A
  • FPF N/A
  • Industry
  • NEO Precision Instruments
  • FPF Trusts Except Educational Religious and Charitable
  • Sector
  • NEO Health Care
  • FPF Finance
  • Exchange
  • NEO Nasdaq
  • FPF Nasdaq
  • Market Cap
  • NEO 1.2B
  • FPF 999.7M
  • IPO Year
  • NEO 1999
  • FPF N/A
  • Fundamental
  • Price
  • NEO $9.55
  • FPF $17.11
  • Analyst Decision
  • NEO Strong Buy
  • FPF
  • Analyst Count
  • NEO 10
  • FPF 0
  • Target Price
  • NEO $19.44
  • FPF N/A
  • AVG Volume (30 Days)
  • NEO 1.9M
  • FPF 186.7K
  • Earning Date
  • NEO 04-29-2025
  • FPF 01-01-0001
  • Dividend Yield
  • NEO N/A
  • FPF 8.08%
  • EPS Growth
  • NEO N/A
  • FPF N/A
  • EPS
  • NEO N/A
  • FPF N/A
  • Revenue
  • NEO $660,566,000.00
  • FPF N/A
  • Revenue This Year
  • NEO $13.06
  • FPF N/A
  • Revenue Next Year
  • NEO $11.18
  • FPF N/A
  • P/E Ratio
  • NEO N/A
  • FPF N/A
  • Revenue Growth
  • NEO 11.65
  • FPF N/A
  • 52 Week Low
  • NEO $8.05
  • FPF $13.91
  • 52 Week High
  • NEO $19.11
  • FPF $18.09
  • Technical
  • Relative Strength Index (RSI)
  • NEO 48.48
  • FPF 40.31
  • Support Level
  • NEO $8.05
  • FPF $16.82
  • Resistance Level
  • NEO $10.18
  • FPF $17.28
  • Average True Range (ATR)
  • NEO 0.72
  • FPF 0.43
  • MACD
  • NEO 0.16
  • FPF -0.03
  • Stochastic Oscillator
  • NEO 70.42
  • FPF 52.61

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.

Share on Social Networks: